Stockhouse Podcasts

Podcast #64 MedMen Enterprises

“A New Cannabis Company for a New Consumer”
The definition of the cannabis consumer is changing and so is the business of the industry. At the forefront of this new wave of thinking is premium cannabis Company MedMen Enterprises (CSE: MMEN, Forum). 
“Breaking the stoner stereotype” to bring marijuana to the mainstream is its mission statement and it’s doing so with 13 operating dispensaries across the United States, employing more than 800 people. The Company listed on the Canadian Securities Exchange on May 29th and before the listing, it was valued at $1.65 billion (US) by investors, making it the first cannabis “unicorn” Company based in the U.S.
As consumption becomes legal in more and more states, it also becomes a more conventional means to treat medical issues. In states where cannabis is legal for recreational purchases, consumers can buy everything from buds, edibles, creams. sprays, drops and even dog treats. The Company also uses a vertically-integrated business model in states that allow it.
MedMen was co-founded in 2010 by CEO Adam Bierman and COO Andrew Modlin. In March 2018, the Company announced its cross-border, joint-venture partnership with Cronos Group called MedMen Canada. This JV plans to open stores across Canada, develop products and retail facilities for the recreational market.
Stockhouse caught up with Adam Bierman to talk about MedMen’s debut on the CSE and what it means for the Company and how it is redefining the cannabis shopping experience.

Blockchain 101 Podcast - Eps 4 - Jonathan Hamel

This is the fourth in our series of Stockhouse Blockchain and Cryptocurrency 101 podcasts. These podcast interviews, with some of the industry's most successful and influential professionals, are designed to help investors understand the complexities and nuances required prior to investing in the cryptocurrency marketplace.   In today's podcast, we talk to Jonathan Hamel – CEO and founder of Académie Bitcoin, a Montreal-based bitcoin and blockchain consulting firm. He is an expert in emerging markets, especially Africa, where he has contributed to various mobile payment and alternative banking projects. A pioneer of the Canadian bitcoin scene, Mr. Hamel has contributed to major financial and technological conferences on all five continents.   Jonathan is a member of the Financial Innovation Committee of L’Autorité des Marchés Financiers (Québec) and has contributed to the Montreal Economic Institute as an Associate Researcher on economic and social issues related to bitcoin and blockchain. He has also appeared before the Canadian House of Commons Standing Committee on Finance to explain how Canada became a leader in the bitcoin industry and why excessive regulation could slow down innovation in the blockchain space.   An experienced world traveler and avid road cycling fan, Jonathan has cycled on all five continents!   He can be found on Twitter @jhamel. His company website is http://academiebitcoin.com/   Jonathan joined us in conversation from his offices in Montréal, Quebec.

Podcast #58 Anaconda Mining Inc

Anaconda Mining Inc. (TSX: ANX, OTCQB: ANXGF, Forum) is a name that is familiar to Stockhouse investors in general, and gold mining investors in Atlantic Canada in particular. For the past 10 years, this TSX-listed gold mining company has been the only gold-producer in the Province of Newfoundland.
In a full-length feature article from January 25, 2018; investors learned about Anaconda’s unique consolidation strategy. This is aimed at boosting its gold production and adding additional ounces-in-the-ground in a very cost-effective manner for the Company and its shareholders.
ANX’s currently producing mine is the Pine Cove Mine (and Mill), part of the Company’s Point Rousse Project, located in Newfoundland’s Baie Verte Mining District. Anaconda is also developing its high-grade Goldboro Gold Project, located in Nova Scotia. However, over the long term, the Company’s largest growth-driver is its Atlantic Canada consolidation strategy.
On April 13, 2018; ANX took an important first step in this strategy when it announced a formal takeover offer for Maritime Resources Corp. (TSX: V.MAE). This is a “hostile” offer in the sense that MAE’s management has refused to engage in a dialogue with Ananconda with respect to combining their operations.
Stockhouse recently had the opportunity to talk with ANX’s President and CEO, Dustin Angelo. We wanted to get more information for the Stockhouse audience on this particular take-over offer and the overall consolidation strategy.
 
FULL DISCLOSURE: Anaconda Mining Inc is a paid client of Stockhouse Publishing.

Blockchain 101 Podcast - Eps 3 - Samson Mow

This is the third in our series of Stockhouse Blockchain and Crypocurrency 101 podcasts. These podcast interviews, with some of the industry's most successful and influential professionals, are designed to help investors understand the complexities and nuances required prior to investing in the cryptocurrency marketplace.
In today's podcast, we talk to Samson Mow, Chief Strategy Office (CSO) with Blockstream – a leading worldwide provider of blockchain technology systems. Prior to joining Blockstream, Mr. Mow was the Chief Operating Officer (COO) of BTCC (BTCChina).
Full bio here: https://blockstream.com/press/2017-04-12-blockstream-welcomes-samson-mow-chief-strategy-officer.html
Mr. Mow has more than 72,000 twitter followers @Excellion. His company website is https://blockstream.com/
Samson joined us in conversation from Victoria British, Columbia.

Blockchain 101 Podcast - Eps 2 - Andrew Kiguel

This is the second in our series of Stockhouse Blockchain and Crypocurrency 101 podcasts. These podcast interviews, with some of the industry's most successful and influential professionals, are designed to help investors understand the complexities and nuances required prior to investing in the cryptocurrency marketplace.
In today's podcast, we talk to Andrew Kiguel President and CEO of Hut 8 Mining Corporation – a Canadian cryptocurrency mining and Blockchain infrastructure company established through an exclusive partnership with Bitfury, one of the world’s leading Blockchain technology companies. Their website is www.hut8mining.com and they can be found TSX Venture Exchange at TSXV:​HUT
Andrew joined us in conversation from his offices in downtown Toronto.

Blockchain 101 Podcast - Eps 1 - Alex Tapscott

This is the first in our series of Stockhouse Blockchain and Cryptocurrency 101 podcasts. These podcast interviews, with some of the industry's most successful and influential professionals, are designed to help investors understand the complexities and nuances required prior to investing in the cryptocurrency marketplace.
In today's podcast, we talk to Alex Tapscott, CEO and Founder of NextBlock Global, co-founder of the Blockchain Research Institute, and author of the best-selling book Blockchain Revolution: How the Technology Behind Bitcoin is Changing Money, Business, and the World. His website is http://www.alextapscott.com/
Alex joined us in conversation from his offices in downtown Toronto.

Podcast #63 Group Eleven Resources Corp.

Earlier this year, the Fraser Institute presented its annual survey of mining and exploration companies, which ranks provinces, states and countries in terms of how their public policies encourage or discourage mining investment. The survey’s Policy Perception Index looks at the overall policy attractiveness of the 91 jurisdictions measured. For the fifth year in a row, the Republic of Ireland took the top spot and that’s where our focus is today. Bart Jaworski is the CEO of Group Eleven Resources, an advanced stage zinc exploration company operating in Ireland.

Podcast #62 Zomedica Pharmaceuticals Corp.

In many respects, animal health is an under-served field. Many of the medications used to treat animal health disorders are actually human drugs, developed for human physiology, and compounded drugs that have not been proven safe or effective for animal use. Similarly, diagnostic procedures for use on animals are also under-developed.
This is the underserved market that is currently being targeted by Zomedica Pharmaceuticals Corp. The Company originally started with a focus on veterinary pharmaceuticals and has since expanded its focus.
As Zomedica began advancing its pipeline of pet pharmaceutical products, the Company’s attention was drawn to a parallel gap in animal healthcare: diagnostics. ZOM has chosen to begin its efforts in this area with the development of a pet-specific diagnostic option for the most serious of diseases: cancer.
2017 was a milestone year for Zomedica. With a market cap of $223.3 million, the Company raised approximately $6.6 million in non-brokered capital alongside a $5 million unsecured working capital loan facility and listed on the NYSE American exchange.
On January 5, 2017; Zomedica announced a research agreement with Celsee Diagnostics, Inc. Celsee is a biotech innovator of rare cell capture, characterization and retrieval products in the emerging field of liquid biopsy. On December 21, 2017; the two companies took their relationship to the next level.
A licensing and supply agreement is now in place for Zomedica to develop and market Celsee’s liquid biopsy technology for veterinary application as a cancer diagnostic. Stockhouse recently caught up with ZOM’s Chief Operations Officer and Vice President of Product Development, Stephanie Morley, DVM, and Chief Financial Officer Shameze Rampertab, CPA, CA, to learn about the clinical and economic potential of this technology.